Colgate-Palmolive (NYSE:CL) announced a quarterly dividend on Thursday, June 10th, RTT News reports. Stockholders of record on Wednesday, July 21st will be given a dividend of 0.45 per share on Monday, August 16th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.15%.
CL stock traded up $1.04 during trading on Thursday, reaching $83.60. The company had a trading volume of 4,075,941 shares, compared to its average volume of 4,645,275. The business has a 50-day simple moving average of $81.73. The firm has a market cap of $70.72 billion, a P/E ratio of 26.87, a price-to-earnings-growth ratio of 4.26 and a beta of 0.61. The company has a debt-to-equity ratio of 11.42, a quick ratio of 0.64 and a current ratio of 1.01. Colgate-Palmolive has a twelve month low of $71.21 and a twelve month high of $86.41.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Thursday, April 29th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.79 by $0.01. The company had revenue of $4.34 billion during the quarter, compared to analysts' expectations of $4.28 billion. Colgate-Palmolive had a net margin of 15.92% and a return on equity of 298.80%. Colgate-Palmolive's revenue for the quarter was up 6.0% on a year-over-year basis. During the same period last year, the business earned $0.75 EPS. As a group, analysts expect that Colgate-Palmolive will post 3.28 earnings per share for the current year.
In related news, Director Stephen I. Sadove sold 8,000 shares of the business's stock in a transaction on Wednesday, May 5th. The shares were sold at an average price of $81.30, for a total value of $650,400.00. Following the completion of the sale, the director now owns 11,324 shares of the company's stock, valued at approximately $920,641.20. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider John W. Kooyman sold 11,195 shares of the business's stock in a transaction on Thursday, May 6th. The stock was sold at an average price of $82.07, for a total transaction of $918,773.65. Following the completion of the sale, the insider now directly owns 19,251 shares of the company's stock, valued at approximately $1,579,929.57. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 91,040 shares of company stock valued at $7,384,255. Insiders own 0.32% of the company's stock.
A number of analysts recently commented on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a "sell" rating to a "hold" rating and set a $85.00 target price for the company in a research note on Monday, May 3rd. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $87.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, April 16th. Credit Suisse Group raised shares of Colgate-Palmolive from a "neutral" rating to an "outperform" rating and raised their price target for the stock from $80.00 to $95.00 in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock a "hold" rating in a research report on Monday, May 3rd. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Colgate-Palmolive presently has an average rating of "Hold" and a consensus target price of $84.42.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
See Also: How does a 12b-1 fee affect fund performance?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: What is the Quick Ratio?7 Stocks to Buy Now and Avoid a Summer Swoon
Summer is generally a quiet time in the markets. Institutional investors, generally speaking, take some time away. In fact, that’s where the idiom “Sell in May and Go Away” comes from.
But quiet doesn’t mean uneventful. The world still moves along even in the lazy months of summer. And at the moment, there are two conflicting views driving the market.
One is the fear that everything’s a bubble that is just about to burst. We don’t recommend you get out of stocks, but let’s face it, things are more than just a little frothy.
But there’s another view summarized by the acronym, YOLO (as in You Only Live Once). And these investors are committed to keeping the markets going higher. Even if it means going “all in” (whatever that means to them) on risky asset classes like NFTs or Dogecoin.
We sincerely hope you take time to recharge (whatever that means to you) this summer. Whatever your personal beliefs, the reopening of our economy is a moment that deserves to be celebrated by all of us. But before you do, we recommend that you take a peek at these seven stocks that you can consider adding to your portfolio before you check out for the summer. These are likely to get as hot as a firecracker on the Fourth of July and should have you smiling when the summer ends.
View the "7 Stocks to Buy Now and Avoid a Summer Swoon"